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 Abstract  
The physical health of people with bipolar disorder is poorer in comparison to the general 
population, with an increased prevalence of cardiovascular and metabolic diseases. Due to the 
established beneficial effects, there is growing interest in the promotion of physical activity and in 
particular the accurate measurement of physical fitness in this population. Currently, no existing 
measures of physical fitness used in the general population have been tested for validity and 
reliability among people with bipolar disorder. Therefore, we examined the reproducibility, feasibility 
and correlates of the Eurofit test battery in people with bipolar disorder. From 24 men (43.0±13.0 
years) and 22 women (43.9±10.2years) with bipolar disorder two trials of the Eurofit test, 
administered within three days, were analyzed. All Eurofit items showed good reproducibility with 
intraclass correlation coefficients ranging from 0.71 for the whole body balance test to 0.98 for the 
handgrip force test. Significant correlations with Eurofit test items were found with age, illness 
duration, body mass index, smoking behaviour, mean daily lithium dosage, and depressive and 
lifetime hypomanic symptoms. The current study demonstrates that the Eurofit test can be 
recommended for evaluating the physical fitness of inpatients with bipolar disorder.  
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1. Introduction 
There are great concerns that the physical health of people with bipolar disorder is significantly 
poorer in comparison to the general population, leading to a considerably shortened life (Osby et al., 
2001, Hoang et al., 2011). Of particular concern is the increased  risk for cardiovascular diseases 
(CVD), with research demonstrating that people with bipolar disorder have a nearly five times 
increased age-, race-, and gender-adjusted CVD risk (Goldstein et al., 2009). The underlying 
mechanisms for this increased CVD-risk are multifactorial and include adverse effects of 
pharmacological treatments (Vancampfort et al., 2013a), poorer access to and quality of physical 
health care (Mitchell et al., 2009; De Hert et al., 2011) and an unhealthy, sedentary lifestyle 
exacerbated by psychiatric symptoms (Killbourne et al., 2009; Vancampfort et al., 2013b). 
Low levels of physical fitness is a strong and independent predictor of CVD and all-cause 
mortality of comparable importance with other CVD risk factors (Wei et al., 1999; Bull and Bauman, 
2011). Physical fitness is a multi-factorial concept comprising a set of more or less independent 
attributes that are related to the ability to perform physical activities. Some of these components are 
more closely related to health, while others are rather related to performance (Pate, 1988). Health-
related physical fitness has been defined as the ability to perform daily activities with vigor and to 
demonstrate capacities that are associated with a lower risk of premature development of 
hypokinetic diseases (i.e., those associated with physical inactivity) (Bouchard and Shephard, 1994). 
Performance-related physical fitness refers to those components that are necessary for optimal work 
or sport performance (Bouchard and Shephard, 1994). Physical fitness includes several components: 
cardio-respiratory fitness, muscular endurance, muscular strength, flexibility, coordination, and 
speed. 
 
To the best of our knowledge, data on the health- and performance related physical fitness in 
people with bipolar disorder are scare. To date, only one study assessed the health- and performance 
related physical fitness in this population and found that patients with bipolar disorder have a 
reduced speed of limb movement (15.8±5.7 vs. 11.8±2.2 sec; p<0.001), explosive leg muscle strength 
(134.9±49.0 vs. 167.6±32.3 cm; p=0.003) and abdominal muscular endurance (11.5±7.8 vs. 18.3±7.6; 
p<0.001). The current lack of research might, in part, be due to lack of appropriate physical fitness 
measures in many mental health care settings (De Hert et al., 2010). For example, laboratory-based 
incremental exercise testing protocols that use breath-by-breath gas analysis and measure the 
maximum level of oxygen consumption (VO2max) are considered the gold standard measurement 
(Vanhees et al., 2005). However, such test protocols only assess cardiorespiratory fitness and no 
other health-related physical fitness components, are time-consuming, costly and need highly 
sophisticated equipment (Vanhees et al., 2005), which is often not available or feasible within mental 
health care settings. Field test batteries assessing all components of physical fitness have been 
developed (Vanhees et al., 2005). Within mental healthcare studies and programs, the Eurofit test 
battery for adults (Oja and Tuxworth, 1995) has been used previously (Van de Vliet et al., 2002; 
Vancampfort et al., 2012). This test battery is designed to assess all components of physical fitness of 
individuals, communities, sub-populations and populations (Oja and Tuxworth, 1995) including 
balance, speed, muscular strength and muscular endurance. The reproducibility and feasibility of the 
Eurofit test battery has however never been assessed in persons with bipolar disorder.  
Considering the lack of appropriate measures to assess the physical fitness of people with 
bipolar disorder, the primary aim of the present study was to investigate the test-retest reliability of 
the Eurofit test battery in this population. Secondary aims were: (a) to describe the feasibility of the 
Eurofit in people with bipolar disorder, and (b) to assess clinical and demographic characteristics 
associated with the performance on the Eurofit. 
 
2. Methods 
2.1. Participants 
Over an 8-month period, inpatients with a DSM-V diagnosis of bipolar disorder (American 
Psychiatric Association, 2013) of the bipolar disorder observation unit of the UPC KU 
Leuven campus Kortenberg in Belgium were invited to participate by their treating 
psychiatrist in the second week of admission.  Reasons for admission were primarily often 
due to either depressive or manic symptoms thus the individuals were deemed in need of 
observation within a specialist service. Only patients with a clinical global impression severity 
scale (Guy, 1976) score of five or less, as assessed by a trained psychiatrist during a semi-
structured interview, and who were able to concentrate for at least half an hour were included. 
Patients admitted to the emergency psychiatric ward were excluded. Participants were 
excluded if they had a co-morbid DSM-V diagnosis of substance abuse during the previous 6 
months. The somatic exclusion criteria included evidence of significant cardiovascular, 
neuromuscular and endocrine disorders which, according to the American College of Sports 
Medicine (2013), might prevent safe participation in the study. All participants received a 
physical examination and baseline electrocardiogram before testing by a specialized 
physician. Participants were also requested to refrain from eating, drinking coffee or smoking 
during a two-hour period prior to the tests. The study procedure was approved by the 
Scientific and Ethical Committee of the UPC KU Leuven, campus Kortenberg, Belgium and 
conducted in accordance with the principles of the Declaration of Helsinki. All participants 
gave their informed written consent. There was no compensation for participation in the 
study. 
2.2. Test-retest of the Eurofit test battery 
A test-retest design was applied to test the reproducibility of several Eurofit test battery items (Oja 
and Tuxworth, 1995). Supervision and measurement of the Eurofit test battery was performed by 
one trained mental health physical therapist following a standardized procedure. The Eurofit test 
battery included 7 items and involved the assessment of the following measures: whole body 
balance, speed of limb movement, flexibility, explosive strength, static strength, abdominal muscular 
endurance and running speed.  
Whole body balance (flamingo balance) was measured as the number of trials needed by 
individuals to achieve a total duration of 30sec in balance on their preferred foot on a flat firm 
surface. While balancing on the preferred foot (shoes removed), the free leg is flexed at the knee and 
the foot of this leg held close to the buttocks. Lower flamingo balance scores indicate a better whole 
body balance.   
Speed of limb movement (plate tapping) was assessed using a table on which two discs at 
80cm distance had to be touched alternately with the preferred hand as fast as possible, completing 
25 cycles. Higher scores indicate lower speed of limb movement.  
Flexibility was measured using the sit-and-reach test. Participants sat on the floor with 
straight legs and reached forward as far as possible (shoes removed). The knees were held in 
extended position by the investigator throughout the test. The feet were placed against a test box 
with a ruler placed on the top of the box. The ruler had to be pushed with the fingertips and this in a 
smooth and slow movement. Higher scores indicate better flexibility. 
Explosive strength was measured by a standing broad jump, using a tape measure on a foam 
mat. Participants were asked to stand behind a line drawn perpendicular to the tape measure and 
jump forward as far as possible using arm swing and knee bending before jumping. The distance 
jumped was recorded from the take-off line to the farthest point backward of the participant. Higher 
scores indicate a better explosive strength.  
Handgrip strength was assessed using a handgrip dynamometer (Lafayette Instruments Hand 
Dynamometer) to be squeezed as forcefully as possible with the preferred arm fully extended slightly 
away from the body, and palm facing inward. Higher scores indicate better handgrip strength.  
Abdominal muscle endurance was measured as the number of correctly completed sit-ups in 
30seconds. Sit-ups were performed with the hands placed at the side of the head, knees bent at 90 
degrees, and the feet secured by the investigator. A full sit-up is defined as touching the knees with 
the elbows and returning the shoulders to the ground. A higher number of completed sit-ups 
indicates greater abdominal muscle endurance. 
 Running speed was assessed using a 10 by 5m shuttle run. Each participant was required to 
sprint 10 times between two lines placed 5m apart over a 1.3 m wide track. The sprint was followed 
by immediately turning and running back. Lower scores indicate better running speed. Except for the 
flamingo balance test, the sit-ups test and the shuttle run, each test was done twice and the better 
score was recorded. 
 
2.3. Anthropometric assessments 
Anthropometric measurements includedbody weight and height.Body weight was measured in light 
clothing to the nearest 0.1kg using a SECA beam balance scale, and height to the nearest 0.1cm using 
a wall-mounted stadiometer.  
 
2.5. Quick Inventory of Depressive Symptomatology self-report (QIDS -SR) 
QIDS-SR (Rush et al., 2003) consists of 16 items each ranging from 0 to 3. It is scored by summing the 
highest response in each of a set of questions relating to sleep, weight and psychomotor symptoms 
and then adding the remaining items. Scores range from 0 to 27 with higher scores indicative of 
higher symptom severity. The QIDS-SR is a standardized measure of depressive symptoms and has 
demonstrated adequate psychometric validity in people with bipolar disorder (Trivedi et al., 2004). 
 
2.6. Hypomania Checklist - 32  
The HCL-32 (Angst et al., 2005) consists of 32 yes/no statements regarding a period when the patient 
remembers being in a high mood. Items ask whether specific behaviors (e.g., “I spend more 
money/too much money”), thoughts (e.g., “I think faster”), or emotions (e.g., “my mood is 
significantly better”) were present in such a state.Scores range from 0 to 32. Higher scores reflect 
more severe hypomanic states. The HCL-32 has been cross-culturally validated including a Belgian 
sub-sample (Angst et al., 2010). 
 
2.7. Medication use 
We recorded the use of antipsychotic medication, antidepressants, mood stabilizers, 
benzodiazepines and anti-cholinergic, anti-epileptic, sleep and somatic medication. Antipsychotic 
medication was recorded and converted into a daily equivalent dosage of chlorpromazine according 
to the consensus of Gardner and colleagues (2010). Mean dosages of specific mood stabilizers, 
antidepressants, benzodiazepines and anti-cholinergic, anti-epileptic, sleep and somatic medication 
were reported when they were used by at least 10 participants. 
 
2.8. Smoking habits 
Smoking behavior was determined  at the day of the first test performance. Participants  were asked 
whether they smoked or not, and if so, how many cigarettes they smoke per day on average.  
 
  
2.9. Statistical analyses 
Continuous data were assessed for normality using the Shapiro-Wilk test and found to be normally 
distributed. Descriptive statistics are therefore presented as mean ± standard deviation (SD). The 
intraclass correlation coefficient (ICC) between the two Eurofit tests using a one-way random single 
measures intraclass correlation analysis and its associated 95% CI (confidence interval) was 
calculated to objectively assess reliability between the two tests.  An acceptable level of reliability 
was defined, acknowledging that such limits are essentially arbitrary. ICC values greater than 0.70 
indicated acceptable reliability (Portney and Watkins, 2000) and were used to determine which 
Eurofit items might be retained or discarded. Pearson correlations were used to compute 
associations between the Eurofit scores and demographical data and other variables. Gender 
differences were assessed using an unpaired t-test. The significance level was set at 0.05. Statistical 
analyses were performed using the statistical package SPSS version 22.0 (SPSS Inc., Chicago, IL). 
 
2.9. Sample size calculation 
An a-priori sample size calculation was conducted following the recommendations of Donner 
and Eliasziw (1987) and Walter et al. (1998). With a more than acceptable intraclass 
correlation coefficient (ICC) of 0.80, and alpha of 0.05 and power of 0.8 (β = 0.2) it was 
established 46 participants were required in the final analysis.  Based on similar research in 
people with severe mental illness (Vancampfort et al., 2012), it was anticipated that 
approximately 15% of patients needed to be excluded, 10% would refuse for motivational 
reasons and 10% would dropout from the testing for both motivational and practical reasons. 
Therefore, a pre-specified sample size of 65-70 participants was utilized to account for these 
factors in order to ensure the final analysis was adequately powered. 
 3. Results 
3.1. Participants 
A total of 69 persons with bipolar disorder were initially recruited. Seven persons with co-morbid 
substance abuse during the previous 6 months were excluded. Three persons were excluded as a 
consequence of a cardiovascular or neuromuscular disorder that might prevent safe participation. Of 
the 59 included persons with bipolar disorder, 8 declined to participate (6 were not interested, 2 
could not be motivated to participate in both occasions). Reasons for additional drop-out were 
discharge from the hospital (n=2), transfer to another hospital (n=1), acute decompensation between 
both test occasions (n=1) and other medical appointments at conflicting times (n=1). Forty-six (42 
with bipolar – I and 4 with bipolar – II disorder) participants were included in the final analysis. 
Within the final sample 24 men (age=43.0±13.0years; illness duration=16.7±12.8years; body mass 
index, BMI=26.0±3.9) and 22 women (43.9±10.2years; illness duration=18.2±9.8years; body mass 
index, BMI=26.6±3.5) were represented. All of the sample apart from one were Belgian natives and 
nineteen (41.3%) of the participants smoked. Men (7/24; 29.2%) smoked 23.6±13.0 cigarettes per 
day, women (12/22; 54.5%) 18.2±9.8. Mean daily equivalent dosage of chlorpromazine (n=45) was 
476.2±301.9mg/day, of lithium carbonate (n=15) 903.1±597.6 mg/day and of valproic acid (n=14) 
1703.6±560.7 mg/day. An overview of the medication of the entire sample (n=46) is presented in 
Table 1. The mean QIDS-SR and HCL-32 score were respectively 7.5±5.0 and 15.6±6.6. 
[Insert Table 1 about here] 
 
 
 
 3.2. Eurofit test battery scores 
A summary of the Eurofit test scores is presented in Table 2 according to gender. Male participants 
had significantly higher explosive muscle strength as measured with the standing broad jump and a 
significantly greater handgrip strength. 
[Insert Table 2 about here] 
 
3.3. Test-retest reliability of the Eurofit items 
The means and standard deviation scores for the first and second Eurofit tests and the associated 
ICC’s with 95% CI’s are presented in Table 3. All Eurofit items demonstrated a minimal acceptable ICC 
above 0.70. The ICC ranged from a minimum of 0.71 for the flamingo balance test to a maximum of 
0.98 for handgrip strength.  
[Insert Table 3 about here] 
 
3.4. Feasibility of the Eurofit test 
Except for the sit-and-reach and the sit-ups test, all Eurofit test items could be completed by all 
participants without any adverse events. Three participants were not able to perform the sit-and-
reach test (see Table 3). Eight participants couldn’t perform the sit-ups (see Table 3).An exploratory 
t-test revealed a significant (p<0.05) older age (52.1±11.3 versus 41.8±11.1 years, p=0.029), longer 
illness duration (27.5±12.1 versus 15.6±10.3 years, p=0.009) and a higher level of depression (QIDS 
score of 11.4±5.3 versus 6.8±4.6, p=0.023) in non-completers compared to completers. No other 
significant differences between completers and non-completers were found.  
  
 
3.4. Correlates for Eurofit parameters 
The r- and p-values for all associations between Eurofit items and demographical and clinical 
variables are presented in Table 4. Except for the scores obtained on the sit-and-reach test and 
handgrip strength test, all Eurofit items were significantly associated with age. Younger patients 
performed better than older patients. A longer illness duration was consistently significantly 
associated with a poorer performance on all Eurofit tests. A higher body mass index was significantly 
correlated with a worse performance on the sit-and-reach test, the sit-ups test and the shuttle run. 
Except for the sit-and-reach test, higher QIDS-SR scores were significantly related to worse test 
performances, while higher HCL-32 scores were only significantly associated with less sit-ups in 
30sec. We did not find significant associations between the dose of antipsychotic medication and 
Eurofit test battery performance. In contrast, the daily dose of lithium carbonate was negatively 
associated with whole body balance. More cigarettes smoked per day was, except for the sit-and-
reach test, significantly related to a poorer performance on the Eurofit. 
Following the correlation analyses, variables significantly correlated with the Eurofit test 
items performances were included in separate regression analyses. 
 
 
 
 
  
 
 
 
4. Discussion 
4.1. Reliability and feasibility of the Eurofit test battery 
To our knowledge, this is the first study investigating the reliability of the Eurofit test in people with 
bipolar disorder. Our findings demonstrate that the Eurofit test may prove useful to assess physical 
fitness in the studied sample and all items demonstrated an acceptable ICC indicating it is 
reproducible and reliable. Except for the whole body balance test and the abdominal muscle 
endurance test, no Eurofit item had to be terminated prematurely and no patient required a rest, 
which is comparable with previous findings in clinical and non-clinical populations (Vancampfort et 
al., 2013d). Given the present observations and its safety profile based on previous studies in people 
with severe mental illness (Van de Vliet et al, 2002; Vancampfort et al., 2012) physician attendance is 
not required if the Eurofit test can be supervised by an experienced physical therapist.  
 
4.2. Correlates of the Eurofit test battery 
In accordance with previous research in people with severe mental illness (Vancampfort et al., 
2013d) a higher BMI was significantly associated with a poorer performance on physical fitness tests 
requiring propulsion or lifting of the body mass (i.e., sit-ups and shuttle run tests). A second reason 
for the poorer performance in more overweight people with bipolar disorder might be the high 
prevalence of physical complaints and pain during physical activities in this sub-population (Stubbs et 
al., 2015). The observation that male patients perform better than women on most Eurofit test items 
has been reported previously (Van de Vliet et al., 2002; Vancampfort et al., 2012) and is in line with 
the general population (Suni et al., 1996). Interestingly, illness duration was a stronger correlate for 
the Eurofit test performance than biological age. It might be hypothesized that a cumulative long-
term effect of poor health behaviors, and longer lifetime exposure to depressive and (hypo)manic 
symptoms and to medication use translate into a poorer physical fitness. In accordance with previous 
research in people with psychotic disorders (Vancampfort et al., 2011), smoking behavior was 
significantly related to a reduced physical fitness. A hypothesis for this association might be that 
people with bipolar disorder who smoke are less physically active than non-smokers due to smoking-
induced respiratory symptoms (e.g. shortness of breath) when being physically active. Less physical 
activity participation may result in impaired muscle strength and endurance. Of particular interest 
was the finding that smoking appears to be highly correlated with reduced balance in this population. 
This may predispose a participant to experience falls and when this is considered alongside the likely 
reduced bone mineral density as seen in other severe mental illness populations (e.g. schizophrenia; 
Stubbs et al 2014), it could mean that this group is at an increased risk of osteoporotic fractures. This 
reduced body balance could lead to self-imposed activity restriction due to concerns about 
experiencing a fall, and may contribute to the low levels of physical activity and further increased 
sensorimotor deconditioning. Whilst this hypothesis seems plausible, further research is required. 
In contrast to people with schizophrenia (Vancampfort et al., 2011) exposure to antipsychotic 
medication was not related to poorer performance on the Eurofit in our bipolar disorder sample. A 
possible explanation might be the lower mean daily equivalent dosage of chlorpromazine equivalents 
in the current study (476±302 mg/day versus 637±434 mg/day). A higher mean daily dosage of 
lithium carbonate was however significantly associated with poorer whole body balance. More 
research in a larger sample is also required here to confirm this finding and to explore any underlying 
mechanisms for the association. The fact that the mean daily dosage of lithium carbonate was not 
associated with speed of limb movement (e.g., plate tapping) was in accordance with previous meta-
analytic data (Wingo et al., 2009). Lastly, related to the psychiatric symptoms associated with the 
Eurofit battery performance, we found that in particular a higher level of depressive symptoms was 
associated with a worse performance, although also higher levels of hypomanic symptoms were 
associated with worse muscle endurance (as measured with the sit-ups tests). It is possible that a 
reduced physical fitness in more depressed participants may be a manifestation of a longstanding 
sedentary lifestyle, while for hypomanic patients it might be the manifestation of a chaotic and 
unhealthy lifestyle. A second reason for the association between feelings of depression and poorer 
performance on the Eurofit might be the fact that feelings of depression are associated with lower 
energy levels, psychomotor retardation, a lower self-efficacy and increased negative outcome 
expectations when having the intention to engage in physical activity (Vancampfort et al., 2011). 
Third, also the low-grade inflammation associated with the manifestation of depressive and 
hypomanic symptoms (Leboyer et al., 2012) might be a hypothesis which should be tested more in 
detail in future research. 
 
4.3. Study limitations and future research 
Whilst this is the first study of its kind, a number of limitations should be considered. First, the 
internal validity could have been improved by adding an age- and gender matched control group. 
Future research comparing Eurofit-scores in people with bipolar disorder with an age and gender 
matched control group from the general population would also provide a valuable point of reference. 
Second, we only included inpatients from one center and questions regarding the generalizability are 
unclear.  However, the sample size was adequately powered and calculated a-priori. Future studies 
should replicate our study to determine whether present results are also applicable to outpatients as 
to inpatients with more acute symptomatology or poorer functioning. Third, we did not include the 
amount of daily physical activity nor an assessment of the current manic symptomatology.  Fourth, 
we did not investigate the role of lower motivation towards performing physical activity during the 
Eurofit test battery performance. Fifth, more research is also needed to understand better the 
influence of mood stabilizers such as lithium carbonate and benzodiazepines on a person’s physical 
fitness. Finally, a few items of the Eurofit-test battery, namely the flamingo balance test, the sit-up 
test and the shuttle run test, were only repeated once at every test occasion. Differences between 
the first and second test might in these cases also represent an effect of familiarization to the test-
item. This might especially explain the relatively low, though acceptable, intraclass correlation 
coefficient of the flamingo balance test.  
Although with limitations, the present study demonstrates that the Eurofit test is a reliable 
and feasible test battery to assess several physical fitness components in inpatients with bipolar 
disorder. Because it is easy to perform and safe, the Eurofit test could be used by experienced 
clinicians (e.g. physical therapists) to assess the important construct of physical fitness in people with 
bipolar disorder.   
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Table 1. 
Medication use among among people with bipolar disorder (n=46) screened prior to 
participation  
Type of medication n 
Antidepressants  
     Mirtazapine 1 
     Trazodone 3 
     Selective Serotonin Reuptake Inhibitors 6 
          Escilatopram 1 
          Sertraline 3 
          Venlafaxine 2 
Mood stabilizers  
     Valproic acid 14 
     Lithium carbonate 15 
Antipsychotic medication  
     Amisulpride 3 
     Aripiprazol 8 
     Clozapine 2 
     Olanzapine 9 
     Paliperidone 4 
     Quetiapine 14 
     Risperidone 2 
Other medication  
     Anticholinergic 2 
     Anti-epilectic (lamotrigin) 4 
     Benzodiazepine 22 
     Sleep medication 3 
     Somatic medication 12 
 
 
 
 
 Table 2. 
Gender differences in Eurofit-scores (retest-trial). 
Physical fitness component Test Men 
n=24 
Women 
n=22 
p 
Whole body balance FBA (number/30sec) 14.4±6.8 15.1±8.6 0.76 
Speed of limb movement PLT (sec) 15.3±5.9 16.3±5.8 0.59 
Flexibility SAR (cm) 17.5±8.8 23.3±11.0 0.07 
Explosive muscle strength SBJ (cm) 152.7±38.0 106.0±47.3 0.001* 
Handgrip strength HGR (kg) 47.4±10.2 30.6±10.9 <0.001* 
Abdominal muscle endurance SUP (number/30sec) 13.4±7.2 11.8±6.1 0.46 
Running speed SHR (sec) 25.5±4.6 29.4±8.1 0.06 
Data are expressed as mean ± SD, *significant (unpaired t-test), FBA=flamingo balance, 
PLT= plate tapping, SAR= sit-and-reach, SBJ=standing broad jump, HGR= handgrip 
strength, SUP=sit-ups, SHR=shuttle run. 
 
  
Table 3. 
Descriptive statistics and intraclass correlation coefficients (ICC) and 95% confidence 
intervals (CI) for the Eurofit test. 
Subtest Completers (n) First test                                                                                                                   Retest ICC 95%CI 
FBA (number/30sec) 46 14.8±7.7 14.9±8.3 0.71 0.54-0.83 
PLT (sec) 46 15.8±5.8 14.9±5.7 0.92 0.86-0.96 
SAR (cm) 43 20.4±10.2 20.0±10.5 0.96 0.93-0.98 
SBJ (cm) 46 128.8±48.6 132.8±52.6 0.92 0.86-0.96 
HGR (kg) 46 38.8±13.4 39.3±12.9 0.98 0.97-0.99 
SUP (number/30sec) 38 12.6±6.7 13.5±6.6 0.96 0.94-0.99 
SHR (sec) 46 27.8±6.8 26.9±6.3 0.94 0.89-0.97 
test-retest data are expressed as mean ± SD, FBA=flamingo balance, PLT= plate tapping, 
SAR= sit-and-reach, SBJ=standing broad jump, HGR= handgrip strength, SUP=sit-ups, 
SHR=shuttle run 
 
  
Table 4. 
Correlations between Eurofit test items (retest-trial) and psychiatric and demographic 
characteristics. 
 FBA PLT SAR SBJ HGR SUP SHR 
Age (yrs) (n=46) 0.39* 0.57*** -0.22 -0.53** -0.26 -
0.58*** 
0.41** 
Illness duration (yrs) 
(n=46) 
0.62*** 0.68*** -0.34* 0.63*** -
0.33* 
-
0.68*** 
0.58*** 
BMI (kg/m²) (n=46) 0.24 0.11 -
0.54** 
-0.23 0.08 -0.36* 0.33* 
QIDS-SR score (n=46) 0.54*** 0.34* -0.18 -0.45** -
0.36* 
-0.39* 0.49** 
HCL-32 score (n=46) -0.007 -0.04 -0.27 -0.01 0.13 -0.33* -0.16 
Daily AP dosea(mg) 
(n=42) 
0.18 0.10 0.07 0.11 0.28 -0.03 -0.06 
Lithium dose (mg/day) 
(n=16) 
0.59* -0.24 -0.44 -0.06 0.25 -0.42 0.23 
Valproic acid (mg/day) 
(n=14) 
0.04 0.25 -0.31 0.008 0.35 0.47 0.16 
Smoking (cig/day) 
(n=19) 
0.79*** 0.62** -0.25 -0.56* -
0.49* 
-0.50* 0.56* 
*p<0.05, **p<0.01,***p<0.001, aexpressed in chlorpromazine equivalents, BMI=body mass 
index, QIDS= Quick Inventory of Depressive Symptomatology, HCL-32= Hypomania 
Checklist - 32, AP= antipsychotic medication, FBA=flamingo balance, PLT= plate tapping, 
SAR= sit-and-reach, SBJ=standing broad jump, HGR= handgrip strength, SUP=sit-ups, 
SHR=shuttle run. 
 
  
Highlights 
• The Eurofit test is a reliable test battery to assess physical fitness in inpatients with bipolar 
disorder admitted to an observation unit. 
• Significant correlations with the Eurofit test items were found with age, illness duration, 
body mass index, smoking behaviour, mean daily lithium dosage, and depressive and 
lifetime hypomanic symptoms. 
 
 
